Identification, isolation and characterization of new impurity in rabeprazole sodium
P Sreenivasa Rao1, Uttam Kumar Ray, P Badarinadh Gupta
1Department of Chemical Research, Aurobindo Pharma Ltd. Research Centre, 313, Bachupally, Quthubullapur Mandal, Hyderabad 500090, India.
Abstract:
Rabeprazole sodium [1] is a proton pump inhibitor, used as an antiulcerative. During the manufacturing of rabeprazole sodium, we observed an unknown impurity at levels 0.05-0.1% in HPLC analysis along with the known potential impurities. This new unknown impurity was isolated using preparative liquid chromatography. Based on the complete spectral analysis ((1)H NMR, (13)C NMR, DEPT, Mass and IR), this new impurity was designated as 2-[[(3-methyl-4-(methylthio)-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole (methylthio impurity of rabeprazole). Impurity isolation, structure elucidation and probable formation mechanism was discussed.
More Related Videos
08:44Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
Published on: May 19, 2026
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Qualitative Analysis
For instance, group IV...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
